Chemistry and Health: Nitrogen Heterocycle Chemistry and Medicinal Chemistry
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 21290
Special Issue Editor
Interests: diazoles; medicinal chemistry; anticancer; antituberculosis; ultrasounds; microwave; organic synthesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Heterocyclic compounds are such an important class of organic compounds that they have their own nomenclature and numbering system. The importance of these compounds derives from the fact that most heterocyclic compounds have biological activity. In fact, nucleic acids, which are the basis for the transmission of genetic information, are natural macromolecular compounds. The monomers from which these macromolecular compounds are derived have a nitrogenous base in their composition. Five heterocyclic compounds derived from purine (adenine and guanine) and pyrimidine (cytosine, thymine, and uracil) are known as nitrogenous bases.
The pharmaceutical industry and modern medicinal science put a lot of effort into their combat with two aggressive life-threatening diseases: cancer and tuberculosis (TB). Both diseases are leading causes of death worldwide, millions of people dying every year; the incidence of both are continually increasing, and the treatments become more and more complicated and sophisticated. The cancer chemotherapy is complex, expensive, and often rather inefficient, because of the large variety of neoplasm types, high toxicity levels, non-specificity of drugs, and the emergence of drug resistance and multidrug-resistance (MDR). On the other hand, because of the Mycobacterium tuberculosis (Mtb) versatility, the treatment against TB has become a challenging and difficult task, and the situation has become even worse because of the phenomena of drug resistance, MDR, extensively drug-resistant (XDR), association of TB with AIDS, etc. It is well known from the literature that imidazole (and its benzo-derivative benzimidazole) and pyridine (and its benzoderivative quinoline) derivatives are core scaffolds widely present in many classes of drugs (of natural or synthetic origin), displaying a large variety of interesting biological activities (antimicrobials, antifungus, anti-inflammatory, antihypertensive, antineuropathic, antihistaminic, etc.; anticancer and anti-TB are also included).
The aim of this Special Issue is to provide a platform to present the latest developments focused on the synthesis of biological active heterocycle derivatives especially (but not only) with anticancer, anti-tuberculosis, and antimicrobial properties.
Prof. Dr. Costel Moldoveanu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heterocycles
- azines
- azoles
- anticancer
- anti-tuberculosis
- antimicrobial
- growth factors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.